Introduction
============

High-grade cervical intraepithelial neoplasia (CIN 2--3) carries a significant risk of developing invasive carcinoma if not treated. Conization is the standard procedure for treatment of high-grade CIN, since it allows histologic confirmation of the lesion, exclusion of invasive cancer, evaluation of the resection margins, and preservation of fertility.[@b1-tcrm-11-851] For young women who desire pregnancy, the surgeon should carefully balance complete excision of the lesion and minimal cervical damage in an attempt to reduce the risk of obstetric complications.

This poses a challenge for doctors to avoid incomplete excision during conization. In fact, there is a considerably high proportion of patients who have incomplete excision after conization. Incomplete excision is undoubtedly associated with an increased risk of residual/recurrent disease being found at subsequent follow-up of women treated by conization. A comprehensive meta-analysis by Ghaem-Maghami et al revealed that the rate of positive margins after conization was about 23.0% (8,091/35,109).[@b2-tcrm-11-851] High-grade post-treatment disease occurred in 18% (597/3,335) of women who had incomplete excision versus 3% (318/12,493) of women who had complete excision.[@b2-tcrm-11-851]

The optimal management of women who have had incomplete excision remains controversial. It is important to avoid overtreatment by secondary excision of uninvolved tissue. However, residual high-grade CIN or invasive carcinoma should be treated without delay. Selecting the most rational treatment modality for women with positive margins is a challenge for both patients and doctors. Therefore, better understanding of the related risk factors for residual precancer or microinvasive cancer is necessary. Accordingly, this study was conducted to determine the clinicopathologic predictors of residual disease in women who had high-grade CIN with margin involvement after initial conization.

Materials and methods
=====================

Patients and clinical data
--------------------------

This retrospective study included 145 patients who were diagnosed as high-grade CIN with positive margins by first conization and underwent subsequent surgical treatment at the Women's Hospital, School of Medicine, Zhejiang University between January 2006 and December 2011. The following data were abstracted from their medical records: demographic characteristics, preoperative cervical cytology, high-risk human papillomavirus (HPV) test results, and all histologic findings. This retrospective analysis was exempt from ethics committee approval at the Women's Hospital, School of Medicine, Zhejiang University, because the committee did not consider approval necessary for a retrospective chart review.

Initial conization and subsequent surgery (repeat conization or hysterectomy)
-----------------------------------------------------------------------------

All operations were performed by senior doctors. In most cases, loop electrosurgical excision procedure (LEEP) was performed in an outpatient setting. The electrical power for the loop electrode was set to a blended mode. The cervix was swabbed with Lugol's iodine solution to assist in locating the ectocervical margin of the lesion. The loop was selected according to the size of the area to be excised. When possible, the cervix lesion was excised en bloc for better orientation and margin status interpretation. When an endocervical extension was suspected, a second selective endocervical sweep was performed. When the ectocervical lesion was too large to be accommodated by a single sweep, excision was achieved with two or more systematic sweeps. The base of the resulting crater was then coagulated by ball diathermy.

Cold knife conization was performed under epidural anesthesia. The cervix was exposed using a weighted posterior vaginal retractor and right angle retractor. After delineating the area of abnormality with Lugol's iodine solution, a circular knife cut approximately 0.5 cm outside the area not stained with iodine was made using a pointed and angled cold knife. The depth of the cone was about 2 cm. The cervicoplasty was completed using a modified Sturmdorf procedure after the necessary electrocoagulation.

All subsequent surgical treatment was performed within 3 months (median 83 days) after the first conization. We attempted to perform repeat conization as the first choice of treatment after a positive margin. Hysterectomy was carried out when repeat conization was technically impossible.

Pathologic examination
----------------------

All cone specimens and the cervical part of hysterectomy were opened longitudinally and sectioned serially along the entire length of the endocervix to the ectocervix at intervals of 2--3 mm and then embedded in paraffin. The surgical margins of the cones were marked with ink. All sections were then stained with hematoxylin and eosin. Cone margin involvement in this study was defined by histologic examination as the presence of neoplastic epithelium consistent with CIN 2--3 at the margin. Residual disease was defined as the presence of any degree of CIN or invasive cancer in specimens of second surgery.

Cytology
--------

The screening cytology was performed and evaluated according to the Bethesda system.[@b3-tcrm-11-851] The liquid-based preparation test (ThinPrep, Hologic, Inc, Bedford, MA, USA) was performed using a soft plastic spatula and endocervical cytobrush. Diagnoses were classified as negative for intraepithelial lesion or malignancy (NILM), atypical squamous cells of undetermined significance (ASCUS), low-grade squamous intraepithelial lesion (LSIL), atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion (ASC-H), high-grade squamous intraepithelial lesion (HSIL), or squamous cell carcinoma (SCC). Cytology was divided into two groups, ie, a minor abnormal group including NILM, ASCUS, and LSIL, and a major abnormal group including ASC-H, HSIL, and SCC.

Detection of high-risk HPV
--------------------------

Analysis of high-risk HPV was performed using Hybrid Capture II tests (Digene, Gaithersburg, MD, USA) from cervical smears according to the manufacturer's instructions. The samples were tested for 13 oncogenic genotypes (types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68), and the results were classified as positive at a relative light unit (RLU)/cutoff ratio of ≥1 pg/mL. Light measurements were quantified using a luminometer and are expressed as the ratio between the RLU of a clinical sample and that of the positive control. The luminescence of a specimen was compared with that of a 1.0 pg/mL HPV-16 cutoff standard.

Statistical analysis
--------------------

Statistical analyses were performed using Statistical Package for the Social Sciences version 16.0 software (SPSS Inc, Chicago, IL, USA). The chi-square or Fisher's exact test was used for univariate identification of factors related to the presence of residual disease. Multivariate analysis was performed using a logistic regression model. All tests were two-sided, and the level of significance was set at *P*\<0.05.

Results
=======

Patient characteristics
-----------------------

The average age of the 145 patients was 43.6±9.1 (range 16--71) years, and 29 were postmenopausal. Gravidity was less than three in 105 patients and parity was less than two in 140 patients. The cytology before first conization showed that nine (6.2%) patients had NILM, 18 (12.4%) had ASCUS, 15 (10.3%) had LSIL, 27 (18.6%) had ASC-H, 59 (40.7%) had HSIL, and two (1.4%) had SCC. The pre-cone high-risk HPV test was positive in 99 patients and negative in 14 patients. The initial conization was performed by LEEP in 69 and cold knife conization in 76 patients. All patient demographic and clinicopathologic characteristics are summarized in [Table 1](#t1-tcrm-11-851){ref-type="table"}.

Residual disease in specimens from subsequent surgery
-----------------------------------------------------

After initial conization, 67 of the 145 patients underwent repeat conization (16 LEEP and 51 cold knife conization), 74 underwent hysterectomy, and four underwent radical trachelectomy; 32.4% (47/145) of the patients had residual disease in specimens from subsequent surgery (five invasive cervical carcinoma, 31 CIN 3, nine CIN 2, and two CIN 1).

Unrecognized invasive cervical carcinoma was observed in five women who underwent extrafascial hysterectomy or modified radical hysterectomy because reconization was technically impossible. The detailed characteristics of these women are shown in [Table 2](#t2-tcrm-11-851){ref-type="table"}.

Risk factors for residual disease
---------------------------------

[Table 3](#t3-tcrm-11-851){ref-type="table"} shows the demographic and clinicopathologic variables in relation to residual disease after conization. Univariate analysis showed significantly higher percentages of residual disease in patients aged ≥35 years, those with menopause, those with major abnormal cytology (ASC-H, HSIL, and SCC), those with pre-cone high-risk HPV ≥300 RLU, and those with positive results of endocervical curettage. However, gravidity, parity, severity of disease, method of conization, glandular extension, and site of margin involvement were not significant factors. Multivariate analysis using a logistic regression model, which included all the above significant covariates, was then performed. According to this analysis, the independent factors significantly predictive of residual disease after conization were age ≥35 years, major abnormal cytology, and pre-cone high-risk HPV load ≥300 RLU ([Table 3](#t3-tcrm-11-851){ref-type="table"}).

Discussion
==========

The American Society for Colposcopy and Cervical Pathology recommends reassessment using cytology with endocervical sampling at 4--6 months after treatment as the preferred option if high-grade CIN is identified at the margins of conization. Repeat conization or hysterectomy, if a repeat conization is not feasible, is acceptable.[@b4-tcrm-11-851] Although most of these patients remain free of disease, the risk of residual disease or even unrecognized invasive cancer is not negligible.[@b5-tcrm-11-851] Both delayed treatment and overtreatment should be avoided with a better understanding of the risk factors in relation to residual disease.

In this study, we found that 32.4% of patients who had high-grade CIN with margin involvement after initial conization had residual disease on subsequent surgical treatment. This finding is similar to the reported incidence of about 20%--60% in previous studies.[@b2-tcrm-11-851],[@b6-tcrm-11-851]--[@b12-tcrm-11-851] Additionally, the incidence of unrecognized invasive cervical carcinoma (3.4%) in this study was also comparable with previously reported incidences of 0.9%--9.6%.[@b6-tcrm-11-851],[@b10-tcrm-11-851]--[@b14-tcrm-11-851]

Risk factors related to CIN residual/recurrent disease after conization may include age, parity, cytologic grade, lesion grade, preoperative and follow-up HPV viral load, HPV genotype, and cone margin involvement. Most authors agree that margin involvement is one of the strongest predictors for residual/recurrent disease.[@b15-tcrm-11-851],[@b16-tcrm-11-851] However, predictors related to residual disease in patients with margin involvement remain uncertain. We systematically evaluated demographic, cytology, pre-cone high-risk HPV, and pathologic variables to determine the relationship with residual disease on second surgery. A logistic regression analysis revealed that age ≥35 years, major abnormal cytology, and pre-cone high-risk HPV load ≥300 RLU were significant independent predictors for residual disease.

Sarian et al reported that women older than 35 years had a significantly higher risk for persistent infection following LEEP, indicating older age as a predictive factor for a residual lesion or increased risk for disease recurrence.[@b17-tcrm-11-851] This is consistent with our results. A retrospective 10-year chart review showed that increasing age and severity of disease in the cone specimen were the only factors that accurately predicted residual dysplasia.[@b8-tcrm-11-851] The odds ratio of residual disease in the hysterectomy specimen for a 40-year-old woman whose odds ratio was 4.9 (95% confidence interval 2.2--10.8) compared with a 25-year-old woman was 2.7 (95% confidence interval 1.6--4.4).

Ryu et al reported that cytologic grade before LEEP was not a significant factor for residual disease or recurrence.[@b18-tcrm-11-851] In contrast, Ayhan et al showed that an HSIL result on a Papanicolaou smear was advantageous for predicting cancer in the repeat conization specimen of women with CIN 3 and a positive ectocervical margin.[@b19-tcrm-11-851] In the present study, cytology was divided into two groups, ie, minor abnormalities included NILM, ASCUS, and LSIL, and major abnormalities included ASC-H, HSIL, and SCC. We found that cytologic grade before conization was also a significant factor for residual disease.

High pre-conization high-risk HPV viral load as a predictor of residual/recurrent disease has been studied by several investigators.[@b20-tcrm-11-851],[@b21-tcrm-11-851] In our study, high-risk HPV viral load, using a cutoff of ≥300 RLU, was a significant risk factor for predicting residual disease after incomplete conization, in agreement with a previous report.[@b11-tcrm-11-851] Ryu et al reported contradictory results; however, they used RLU of 100 as the cutoff value for a high viral load.[@b18-tcrm-11-851]

Although specific characteristics of patients with unrecognized invasive cancer could not be closely addressed in the present study due to the small study population, we found that 80% (4/5) of these women were postmenopausal. Consequently, the post-treatment surveillance for postmenopausal women who had margin involvement with high-grade CIN should be undertaken carefully if secondary surgery has not been performed.

In summary, multivariate analysis showed that age ≥35 years, major abnormal cytology, and pre-cone high-risk HPV load ≥300 RLU were predictive of post-cone residual disease for women who had margin involvement with high-grade CIN. Appropriate application of these predictive factors may further decrease the incidence of delayed treatment and over treatment.
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###### 

Patient characteristics (n=145)

  Characteristics        Patients, n (%)
  ---------------------- -----------------
  Age (years)            
   ≤35                   28 (19.3)
   \>35                  117 (80.7)
  Menopause              
   No                    119 (82.1)
   Yes                   26 (17.9)
  Gravidity              
   ≤3                    105 (72.4)
   \>3                   40 (27.6)
  Parity                 
   ≥2                    140 (96.6)
   \>2                   5 (3.4)
  Cytology               
   NILM                  9 (6.2)
   ASCUS                 18 (12.4)
   LSIL                  15 (10.3)
   ASC-H                 27 (18.6)
   HSIL                  59 (40.7)
   SCC                   2 (1.4)
   No data               15 (10.3)
  High-risk HPV          
   Positive              99 (68.3)
   Negative              14 (9.7)
   No data               32 (22.1)
  Method of conization   
   LEEP                  69 (47.6)
   CKC                   76 (52.4)

**Abbreviations:** NILM, negative for intraepithelial lesion or malignancy; ASCUS, atypical squamous cells of undetermined significance; LSIL, low-grade squamous intraepithelial lesion; ASC-H, atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion; HSIL, high-grade squamous intraepithelial lesion; SCC, squamous cell carcinoma; HPV, human papillomavirus; LEEP, loop electrosurgical excision procedure; CKC, cold knife conization.

###### 

Characteristics of the five women who had residual cervical cancer

  Characteristics           Case 1           Case 2           Case 3            Case 4           Case 5
  ------------------------- ---------------- ---------------- ----------------- ---------------- ----------------
  Age (years)               53               51               56                37               56
  Menopause                 Yes              Yes              Yes               No               Yes
  Cytology                  HSIL             HSIL             HSIL              ASCUS            ASC-H
  High-risk HPV (RLU)       354.8            35.3             4,710             Negative         No data
  Method of conization      CKC              CKC              LEEP              CKC              CKC
  Diagnosis by conization   CIN 3            CIN 3            CIN 3             CIN 2            CIN 3
  Margin involvement        Endo             Endo             Endo/Ecto         Ecto             Ecto
  Second surgery            EH               MRH              EH                EH               MRH
  Final diagnosis           Stage 1 A1 SCC   Stage 1 A2 SCC   Stage 11 A1 SCC   Stage 1 A1 SCC   Stage 1 A2 SCC

**Abbreviations:** Ecto, ectocervical; Endo, endocervical; EH, extrafascial hysterectomy; MRH, modified radical hysterectomy; SCC, squamous cell carcinoma; HPV, human papillomavirus; RLU, relative light unit; LEEP, loop electrosurgical excision procedure; CKC, cold knife conization; ASCUS, atypical squamous cells of undetermined significance; ASC-H, atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion; HSIL, high-grade squamous intraepithelial lesion; CIN, cervical intraepithelial neoplasia.

###### 

Univariate and multivariate analyses for prediction of residual disease after initial conization

  -----------------------------------------------------------------------------------------------------------------------------------------------------
  Parameter                                                                               Residual rate (%)   Univariate   Multivariate         
  ---------------------------------------------------------------- ---------------------- ------------------- ------------ -------------------- -------
  Age (years)                                                      ≤35\                   4/28 (14.3)\        0.023        3.61 (1.11--11.78)   0.033
                                                                   \>35                   43/117 (36.8)                                         

  Menopause                                                        No\                    32/119 (26.9)\      0.02         1.64 (0.89--3.25)    0.146
                                                                   Yes                    15/26 (57.7)                                          

  Gravidity                                                        ≤3\                    32/105 (30.5)\      0.419        Variable removed     
                                                                   \>3                    15/40 (37.5)                                          

  Parity                                                           ≤2\                    45/140 (32.1)\      0.712        Variable removed     
                                                                   \>2                    2/5 (40)                                              

  Cytology[a](#tfn4-tcrm-11-851){ref-type="table-fn"}              Minor abnormalities\   7/42 (16.7)\        0.001        3.40 (1.55--7.45)    0.002
                                                                   Major abnormalities    59/88 (67.0)                                          

  High-risk HPV (RLU)[b](#tfn5-tcrm-11-851){ref-type="table-fn"}   ≤300\                  11/47 (23.4)\       0.002        1.99 (1.18--3.39)    0.011
                                                                   \>300                  31/66 (47)                                            

  Method of conization                                             LEEP\                  27/69 (39.1)\       0.078        Variable removed     
                                                                   CKC                    20/76 (26.3)                                          

  ECC                                                              Negative\              39/134 (29.1)\      0.003        1.74 (1.02--3.08)    0.091
                                                                   Positive               8/11 (72.7)                                           

  Neoplastic severity                                              CIN 2\                 7/23 (30.4)\        0.825        Variable removed     
                                                                   CIN 3                  40/122 (32.8)                                         

  Glandular involvement                                            No\                    3/8 (37.5)\         0.752        Variable removed     
                                                                   Yes                    44/137 (32.1)                                         

  Site of margin involvement                                       Endo\                  31/81 (38.3)\       0.241        Variable removed     
                                                                   Ecto\                  11/47 (23.4)\                                         
                                                                   Endo/Ecto              5/17 (29.4)                                           
  -----------------------------------------------------------------------------------------------------------------------------------------------------

**Notes:** Minor abnormalities include NILM + ASCUS + LSIL; major abnormalities include ASC-H + HSIL + SCC.

15 cases without data;

32 cases without data.

**Abbreviations:** NILM, negative for intraepithelial lesion or malignancy; ASCUS, atypical squamous cells of undetermined significance; LSIL, low-grade squamous intraepithelial lesion; ASC-H, atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion; HSIL, high-grade squamous intraepithelial lesion; SCC, squamous cell carcinoma; OR, odds ratio; CI, confidence interval; RLU, relative light unit; HPV, human papillomavirus; CIN, cervical intraepithelial neoplasia; Ecto, ectocervical; Endo, endocervical; LEEP, loop electrosurgical excision procedure; CKC, cold knife conization; ECC, endocervical curettage.

[^1]: \*These authors contributed equally to this work
